Glycosylation: mechanisms, biological functions and clinical implications

M He, X Zhou, X Wang - Signal Transduction and Targeted Therapy, 2024 - nature.com
Protein post-translational modification (PTM) is a covalent process that occurs in proteins
during or after translation through the addition or removal of one or more functional groups …

Advances in mass spectrometry imaging for spatial cancer metabolomics

X Ma, FM Fernández - Mass spectrometry reviews, 2024 - Wiley Online Library
Mass spectrometry (MS) has become a central technique in cancer research. The ability to
analyze various types of biomolecules in complex biological matrices makes it well suited for …

Glycosylation of cancer extracellular vesicles: capture strategies, functional roles and potential clinical applications

ÁM Martins, CC Ramos, D Freitas, CA Reis - Cells, 2021 - mdpi.com
Glycans are major constituents of extracellular vesicles (EVs). Alterations in the
glycosylation pathway are a common feature of cancer cells, which gives rise to de novo or …

The role of O-glycosylation in human disease

A Magalhães, HO Duarte, CA Reis - Molecular Aspects of Medicine, 2021 - Elsevier
O-glycosylation is a highly frequent post-translation modification of proteins, with important
functional implications in both physiological and disease contexts. The biosynthesis of O …

Tumor-associated O-glycans of MUC1: Carriers of the glyco-code and targets for cancer vaccine design

DM Beckwith, M Cudic - Seminars in immunology, 2020 - Elsevier
The transformation from normal to malignant phenotype in human cancers is associated with
aberrant cell-surface glycosylation. It has frequently been reported that MUC1, the heavily …

Different isolation approaches lead to diverse glycosylated extracellular vesicle populations

D Freitas, M Balmaña, J Poças, D Campos… - Journal of …, 2019 - Taylor & Francis
Extracellular vesicles (EVs) are a heterogeneous group of small secreted particles involved
in intercellular communication and mediating a broad spectrum of biological functions. EVs …

Syndecan-4 is a maestro of gastric cancer cell invasion and communication that underscores poor survival

J Poças, C Marques, C Gomes… - Proceedings of the …, 2023 - National Acad Sciences
Gastric cancer is a dominating cause of cancer-associated mortality with limited therapeutic
options. Here, we show that syndecan-4 (SDC4), a transmembrane proteoglycan, is highly …

[HTML][HTML] Nanoparticles targeting Sialyl-Tn for efficient tyrosine kinase inhibitor delivery in gastric cancer

F Diniz, S Lamas, H Osório, P Aguiar, D Freitas… - Acta Biomaterialia, 2023 - Elsevier
Gastric cancer (GC) is the fourth leading cause of cancer-related deaths worldwide and,
therefore, it is urgent to develop new and more efficient therapeutic approaches. Foretinib …

Glycans as targets for drug delivery in cancer

F Diniz, P Coelho, HO Duarte, B Sarmento, CA Reis… - Cancers, 2022 - mdpi.com
Simple Summary Alterations in glycosylation are frequently observed in cancer cells.
Different strategies have been proposed to increase drug delivery to the tumor site in order …

ST6Gal1 targets the ectodomain of ErbB2 in a site-specific manner and regulates gastric cancer cell sensitivity to trastuzumab

HO Duarte, JG Rodrigues, C Gomes, PJ Hensbergen… - Oncogene, 2021 - nature.com
The clinical performance of the therapeutic monoclonal antibody trastuzumab in the
treatment of ErbB2-positive unresectable gastric cancer (GC) is severely hampered by the …